[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$dsnky Graphic](https://lunarcrush.com/gi/w:26/t:$dsnky.png) $dsnky

$DSNKY sees a surge in social engagement due to positive clinical trial results. Oppenheimer initiates coverage on $CTMX, potentially impacting $DSNKY's value and driving sector interest.  

### About $dsnky
A financial asset, likely a stock or cryptocurrency, identified by the ticker symbol $DSNKY.  

### Engagements: XXX [#](/topic/$dsnky/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$dsnky/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$dsnky/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXXXX  
**1 Week**: XXXXX -XX%  
**1 Month**: XXXXX -XX%  
**1-Year High**: XXXXXX on 2025-05-23  
**1-Year Low**: XX on 2025-07-06  

| Social Network | X   |
| -------------- | -   |
| Engagements    | XXX |
  

  
  
### Mentions: X [#](/topic/$dsnky/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$dsnky/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$dsnky/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1-Year High**: XX on 2025-07-15  
**1-Year Low**: X on 2025-08-19  

| Social Network | X  |
| -------------- | -  |
| Mentions       | XX |
  

  
  
### Creators: X [#](/topic/$dsnky/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$dsnky/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$dsnky/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $dsnky in the last XX hours which is down XX% from X in the previous XX hours
**Daily Average**: X  
**1-Year High**: XX on 2025-07-15  
**1-Year Low**: X on 2025-05-18  

The most influential creators that mention $dsnky in the last XX hours

| Creator                                      | Rank | Followers | Posts | Engagements |
| -------                                      | ---- | --------- | ----- | ----------- |
| [@JacobPlieth](/creator/twitter/JacobPlieth) | X    | XXXXXX    | X     | XXX         |

[View More](/list/creators/$dsnky/100)
  
  
### Sentiment: XXX% [#](/topic/$dsnky/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$dsnky/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$dsnky/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XXX% no change  
**1-Year High**: XXX% on 2025-04-30  
**1-Year Low**: XX% on 2025-06-03  

**Most Supportive Themes**
- **Clinical Trial Updates:** (60%) Positive sentiment around clinical trial updates for $DSNKY, particularly regarding Enhertu's performance in breast cancer trials.
- **Oppenheimer Coverage of $CTMX:** (20%) Initiation of coverage by Oppenheimer on $CTMX with an Outperform rating, boosting sector interest.
  
**Most Critical Themes**
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XX       | XX% | XXX     | XX% | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XX       | XX% | XXX     | XX% | X        | X% |
  


**Top assets mentioned**
In the posts about $dsnky in the last XX hours

[AstraZeneca PLC (AZN)](/topic/$azn)
[Pfizer, Inc. (PFE)](/topic/$pfe)
[Gilead Sciences, Inc. (GILD)](/topic/gilead-sciences)
[Incyte Corporation (INCY)](/topic/$incy)
[Moderna Inc (MRNA)](/topic/$mrna)
[Eli Lilly and Company (LLY)](/topic/eli-lilly)
[Eli Lilly and Company (LLY)](/topic/$lly)
[IDEAYA Biosciences, Inc. Common Stock (IDYA)](/topic/$idya)
[Amgen, Inc. (AMGN)](/topic/$amgn)
[Gilead Sciences, Inc. (GILD)](/topic/$gild)

**Top topics mentioned**
In the posts about $dsnky in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [$azn](/topic/$azn), [$8750t](/topic/$8750t), [$pfe](/topic/$pfe), [gilead sciences](/topic/gilead-sciences), [$incy](/topic/$incy), [$mrna](/topic/$mrna), [eli lilly](/topic/eli-lilly), [$lly](/topic/$lly), [breast cancer](/topic/breast-cancer), [manat](/topic/manat), [$gmabco](/topic/$gmabco), [$argx](/topic/$argx), [$43b](/topic/$43b), [$idya](/topic/$idya), [$amgn](/topic/$amgn), [$gild](/topic/$gild), [$cgen](/topic/$cgen), [china](/topic/china), [$bntx](/topic/$bntx), [$bny](/topic/$bny), [$smmt](/topic/$smmt), [$abbny](/topic/$abbny), [$alpmy](/topic/$alpmy), [$arkay](/topic/$arkay), [$ayi](/topic/$ayi), [$azz](/topic/$azz), [nov inc](/topic/nov-inc), [stocks energy](/topic/stocks-energy), [$nov](/topic/$nov), [$akro](/topic/$akro)

### Top Social Posts [#](/topic/$dsnky/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$AZN $CGEN $DSNKY DATROWAY Plus Rilvegostomig Showed Promising Tumor Responses in Patients with Metastatic Urothelial Cancer in TROPION-PanTumor03 Phase X Trial - A confirmed objective response rate of XXXX% and a disease control rate of XXXX% was observed with Daiichi Sankyo and AstraZenecas DATROWAY in combination with rilvegostomig in previously untreated cisplatin ineligible patients _ TROPION-Urothelial03 phase 2/3 trial initiated to further evaluate the role of DATROWAY plus platinum-based chemotherapy in previously treated metastatic urothelial cancer"  
[X Link](https://x.com/MarcJacksonLA/status/1979230983019991372) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2025-10-17T17:00Z 7583 followers, XXX engagements


"#ESMO25 regular abstracts are now live with first-in-human data being revealed by $LLY $INCY $DSNKY $MRNA $NVS Parabilis & others. Preview via @ApexOnco"  
[X Link](https://x.com/JacobPlieth/status/1977743598129926308) [@JacobPlieth](/creator/x/JacobPlieth) 2025-10-13T14:29Z 30.9K followers, 6401 engagements


"$NOV $AKRO $PFE $BBIO $ALNY $IONS $RNA $DYN $GILD $NOVN $AZN $MRK $DSNKY $RHHBY $LLY $IPSEY $TAK $HCM $BAYRY Listen to ESMO Preview; Cardio Rivalry; DM1 Race: BI Drug Call by Bloomberg Intelligence #np on #SoundCloud"  
[X Link](https://x.com/SamFazeli8/status/1977652124654719288) [@SamFazeli8](/creator/x/SamFazeli8) 2025-10-13T08:26Z 2884 followers, 1099 engagements


"AstraZeneca: Integrate preCISION to extend #Enhertus reach significantly improve dosing potential & move TOP1 chemistry into new tumour types. Frees them from dependency on $DSNKY and creates a next-gen deruxtecan. 2/4 #AVCT $AZN #AZN"  
[X Link](https://x.com/tom_the_bomb__/status/1976221097927618929) [@tom_the_bomb__](/creator/x/tom_the_bomb__) 2025-10-09T09:40Z 3311 followers, 1804 engagements